Carl Frank Schanbacher
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Carl Frank Schanbacher has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Kjetil K. Guldbakke
4 shared publicationsAbel Torres
Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, and Mohs Surgery Center, Dana Farber Cancer Institute, Boston, Massachusetts
1 shared publicationDiego E. Marra
Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, and Mohs Surgery Center, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
1 shared publicationJoshua Brodsky
1 shared publicationJulia P. Mb Tolland
Department of Dermatology, Royal Hospital's Trust, Grosvenor Road, Belfast, Northern Ireland
1 shared publicationJulia P. Tolland
Department of Dermatology, Royal Hospital's Trust, Grosvenor Road, Belfast, Northern Ireland
1 shared publication
Latest Publications
- 1 March 2008
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 34 (3) , 407-413
Human Papillomavirus Type 73 in Primary and Recurrent Periungual Squamous Cell Carcinoma
- 1 March 2008
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 34 (3) , 407-413
Human Papillomavirus Type 73 in Primary and Recurrent Periungual Squamous Cell Carcinoma
- 17 December 2007
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 34 (2) , 264-270
Hemorrhagic Foreign Body Granuloma after Cutaneous Surgery Occurring in the Setting of Aspirin Therapy or Thrombocytopenia: A Presentation of Six Cases
- 17 December 2007
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 34 (2) , 264-270
Hemorrhagic Foreign Body Granuloma after Cutaneous Surgery Occurring in the Setting of Aspirin Therapy or Thrombocytopenia: A Presentation of Six Cases
- 1 October 2006
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 32 (10) , 1294-1301
Mohs Micrographic Surgery, Sentinel Lymph Node Mapping, and Estrogen Receptor Analysis for the Treatment of Malignant Nodular Hidradenoma
- 1 October 2006
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 32 (10) , 1294-1301
Mohs Micrographic Surgery, Sentinel Lymph Node Mapping, and Estrogen Receptor Analysis for the Treatment of Malignant Nodular Hidradenoma
- 1 October 2006
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 32 (10) , 1294-1301
Mohs Micrographic Surgery, Sentinel Lymph Node Mapping, and Estrogen Receptor Analysis for the Treatment of Malignant Nodular Hidradenoma
- 1 October 2006
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 32 (10) , 1294-1301
Mohs Micrographic Surgery, Sentinel Lymph Node Mapping, and Estrogen Receptor Analysis for the Treatment of Malignant Nodular Hidradenoma
- 1 May 2006
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 32 (5) , 760-764
Disseminated Intravascular Coagulation Unmasked by Mohs Micrographic Surgery
- 1 May 2006
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 32 (5) , 760-764
Disseminated Intravascular Coagulation Unmasked by Mohs Micrographic Surgery
- 1 May 2004
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 30 (5) , 799-802
Mohs Micrographic Surgery of Primary Cutaneous Mucinous Carcinoma Using Immunohistochemistry for Margin Control
Primary cutaneous mucinous carcinoma is a rare adnexal malignancy with a high recurrence rate following conventional excision and the potential for aggressive local invasion. To enhance the microscopic detection of mucinous carcinoma in Mohs micrographic surgical sections by incorporating rapid immunohistochemical staining. Standard Mohs micrographic surgical technique was used in conjunction with frozen section immunohistochemistry using an antibody to low-molecular-weight cytokeratin. Rapid immunoperoxidase staining using low-molecular-weight cytokeratin detected residual foci of mucinous carcinoma that were difficult to identify on routine frozen sections. Immunostaining was strongly positive in areas with clear evidence of tumor by routine histology, as well as in adjacent areas on a subsequent stage where frozen sections were equivocal or negative. Immunostaining was distinctly negative at the final surgical margin, which was shown by en face permanent sections to be free of tumor. The patient has been free of recurrence for 3 years. Immunoperoxidase-guided Mohs micrographic surgery using low-molecular-weight cytokeratin enhances the sensitivity for detection of mucinous carcinoma, and may help contribute to complete tumor removal.
- 1 May 2004
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 30 (5) , 799-802
Mohs Micrographic Surgery of Primary Cutaneous Mucinous Carcinoma Using Immunohistochemistry for Margin Control
Primary cutaneous mucinous carcinoma is a rare adnexal malignancy with a high recurrence rate following conventional excision and the potential for aggressive local invasion. To enhance the microscopic detection of mucinous carcinoma in Mohs micrographic surgical sections by incorporating rapid immunohistochemical staining. Standard Mohs micrographic surgical technique was used in conjunction with frozen section immunohistochemistry using an antibody to low-molecular-weight cytokeratin. Rapid immunoperoxidase staining using low-molecular-weight cytokeratin detected residual foci of mucinous carcinoma that were difficult to identify on routine frozen sections. Immunostaining was strongly positive in areas with clear evidence of tumor by routine histology, as well as in adjacent areas on a subsequent stage where frozen sections were equivocal or negative. Immunostaining was distinctly negative at the final surgical margin, which was shown by en face permanent sections to be free of tumor. The patient has been free of recurrence for 3 years. Immunoperoxidase-guided Mohs micrographic surgery using low-molecular-weight cytokeratin enhances the sensitivity for detection of mucinous carcinoma, and may help contribute to complete tumor removal.